{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:59:21Z","timestamp":1782878361087,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jcf.2025.12.002","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:35:23Z","timestamp":1765802123000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pregnancies in women with cystic fibrosis in the era of CFTR modulators: Current challenges and future perspectives. Insights from the Italian cystic fibrosis registry"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-2610","authenticated-orcid":false,"given":"Marco","family":"Salvatore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1884-9171","authenticated-orcid":false,"given":"Giuseppe","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3593-9774","authenticated-orcid":false,"given":"Daniela","family":"Pierannunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0789-2745","authenticated-orcid":false,"given":"Pietro","family":"Ripani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-5381","authenticated-orcid":false,"given":"Giovanni","family":"Taccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2358-5470","authenticated-orcid":false,"given":"Benedetta","family":"Fabrizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2548-8893","authenticated-orcid":false,"given":"Fabio","family":"Majo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-8125","authenticated-orcid":false,"given":"Rita","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jcf.2025.12.002_bib0001","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.3390\/ijms25179599","article-title":"Cystic fibrosis: a journey through time and hope","volume":"25","author":"Trouv\u00e9","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jcf.2025.12.002_bib0002","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/jama.1966.03100120061014","article-title":"Pregnancy in cystic fibrosis of the pancreas","volume":"195","author":"Grand","year":"1966","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.002_bib0003","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/jcm12041468","article-title":"Pregnancy in Cystic fibrosis-past, present, and future","volume":"12","author":"Gur","year":"2023","journal-title":"J Clin Med"},{"issue":"19","key":"10.1016\/j.jcf.2025.12.002_bib0004","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.jcf.2025.12.002_bib0005","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.002_bib0006","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2018.10.009","article-title":"Failure to conceive in woman with CF is associated with pancreatic insufficiency and advancing age","volume":"18","author":"Shteinberg","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.002_bib0007","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","article-title":"Standards for the care of people with cystic fibrosis (CF); planning for a longer life","volume":"23","author":"Gramegna","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.12.002_bib0008","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.rmed.2018.11.009","article-title":"A case-control study on pregnancy in Italian Cystic Fibrosis women. Data from the Italian Registry","volume":"145","author":"Giordani","year":"2018","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.jcf.2025.12.002_bib0009","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/aogs.14190","article-title":"Perinatal outcomes in women with cystic fibrosis: data from the Italian Cystic Fibrosis Registry","volume":"100","author":"Padoan","year":"2021","journal-title":"Acta Obs Gynecol Scand"},{"key":"10.1016\/j.jcf.2025.12.002_bib0010","unstructured":"Cystic Fibrosis Foundation Patient Registry 2023 Annual Data Report. Cystic Fibrosis Foundation, 2024. Available at: https:\/\/www.cff.org\/medical-professionals\/patient-registry [Accessed 06\/2025]."},{"key":"10.1016\/j.jcf.2025.12.002_bib0011","unstructured":"UK Cystic Fibrosis Registry - 2022 Annual Data Report. Available at: https:\/\/www.cysticfibrosis.org.uk\/about-us\/uk-cf-registry [Accessed 06\/2025]."},{"key":"10.1016\/j.jcf.2025.12.002_bib0012","unstructured":"World Population Prospects. Population Division, United Nations. Available at: https:\/\/population.un.org [Accessed 06\/2025]."},{"issue":"3","key":"10.1016\/j.jcf.2025.12.002_bib0013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcf.2020.12.011","article-title":"Elexacafator\/tezacaftor\/ivacaftor resolves subfertility in females with CF: a two center case series","volume":"20","author":"O'Connor","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.12.002_bib0014","first-page":"25","article-title":"Potential impact on fertility of new systemic therapies for cystic fibrosis","author":"ones","year":"2015","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"10.1016\/j.jcf.2025.12.002_bib0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/jpm11050418","article-title":"Pregnancy and lactation considerations for women with CF in the CFTR modulator era","volume":"11","author":"Jain","year":"2021","journal-title":"J Pers Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.12.002_bib0016","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00404-023-07153-y","article-title":"Unplanned pregnancies following the introduction of elexacaftor\/tezacaftor\/ivacaftor therapy in women with cystic fibrosis","volume":"308","author":"Dacc\u00f2","year":"2023","journal-title":"Arch Gynecol Obs"},{"key":"10.1016\/j.jcf.2025.12.002_bib0017","author":"Donati"},{"issue":"8","key":"10.1016\/j.jcf.2025.12.002_bib0018","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1034\/j.1600-0412.2002.810803.x","article-title":"Maternal and fetal morbidity in pregnancies of Norwegian and Swedish women with cystic fibrosis","volume":"81","author":"\u00d8degaard","year":"2002","journal-title":"Acta Obs Gynecol Scand"},{"key":"10.1016\/j.jcf.2025.12.002_bib0019","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rmed.2016.02.010","article-title":"Maternal and perinatal outcomes of pregnancies in women with cystic fibrosis-A single centre case-control study","volume":"113","author":"Girault","year":"2016","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.002_bib0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcf.2025.03.002","article-title":"CFTR modulators and pregnancy outcomes: early findings from a nationwide cohort study","volume":"24","author":"Chouchana","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.002_bib0021","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/1471-0528.12040","article-title":"The outcome of pregnancies in women with cystic fibrosis\u2013single centre experience 1998-2011","volume":"120","author":"Thorpe-Beeston","year":"2013","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.002_bib0022","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1753495X221146342","article-title":"Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era","volume":"16","author":"Davidson","year":"2023","journal-title":"Obs Med"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.002_bib0023","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jcf.2025.02.004","article-title":"The impact of pregnancy on mortality and lung function in cystic fibrosis patients","volume":"24","author":"Mohabir","year":"2025","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.12.002_bib0024","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcf.2018.05.009","article-title":"Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding","volume":"17","author":"Trimble","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.12.002_bib0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcf.2021.12.004","article-title":"Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor","volume":"21","author":"Collins","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"24","key":"10.1016\/j.jcf.2025.12.002_bib0026","first-page":"01843","article-title":"Outcomes of prenatal use of elexacaftor\/tezacaftor\/ivacaftor in carrier mothers to treat meconium ileus in foetuses with cystic fibrosis","volume":"S1569-1993","author":"Metcalf","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.12.002_bib0027","doi-asserted-by":"crossref","unstructured":"Fortner C.N., Seguin J.M., Kay D.M. Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy. J Cyst Fibros;20:835\u20136.","DOI":"10.1016\/j.jcf.2021.03.018"},{"issue":"6","key":"10.1016\/j.jcf.2025.12.002_bib0028","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jcf.2022.10.004","article-title":"Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.12.002_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1265138","article-title":"Ocular development after highly effective modulator treatment early in life","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2025.12.002_bib0030","article-title":"Maternal, newborn and breast milk concentrations of elexacaftor \/tezacaftor \/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy","volume":"10","author":"Ripani","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.002_bib0031","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2025.12.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01208-2019","article-title":"ERS\/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases","volume":"55","author":"Middleton","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.12.002_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2007.10.001","article-title":"European Cystic Fibrosis Society. Guidelines for the management of pregnancy in women with cystic fibrosis","author":"Edenborough","year":"2008","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325025342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325025342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:01:10Z","timestamp":1768881670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325025342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1569199325025342"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancies in women with cystic fibrosis in the era of CFTR modulators: Current challenges and future perspectives. Insights from the Italian cystic fibrosis registry","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}